Clinical trial
Hybrid APC Therapy in Early Central Lung Neoplasms
NCT03537378
Study timeline
Study start (actual)2018-12-26Date precision: day
Registry last updated2025-07-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Neoplasmsunresolved
Interventions
Hybrid APCPROCEDURE
Sponsors & collaborators
Jiayuan Sunlead sponsor
Shanghai Pulmonary Hospital, Shanghai, Chinacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03537378 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.